MCP-1 gene A-2518G polymorphism and carotid artery atherosclerosis in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 86, Issue 3, 2009, Pages 193-198

  Yuasa, Sachiko ^a   Maruyama, Taro ^b   Yamamoto, Yukihiro ^a   Hirose, Hiroshi ^a   Kawai, Toshihide ^a   Matsunaga Irie, Seiko ^a   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA SOCIAL INSURANCE HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Intima media thickness (IMT); MCP 1; SNP; Type 2 diabetes

Indexed keywords

ALANINE; GLYCINE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1;

AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADENINE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERY DISEASES; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; THYMINE;

EID: 70350618783     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.09.001     Document Type: Article

References (29)

1. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352 (2005) 1685-1695
3. Beckman J.A., Creager M.A., and Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287 (2002) 2570-2581
4. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610-621
5. Takeya M., Yoshimura T., Leonard E.J., and Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24 (1993) 534-539
6. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 5252-5256
7. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 187 (1998) 601-608
8. Gu L., Okada Y., Clinton S.K., Gerard C., Sukhova G.K., Libby P., et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2 (1998) 275-281
9. Aiello R.J., Bourassa P.A., Lindsey S., Weng W., Natoli E., Rollins B.J., et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1518-1525
10. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun. 259 (1999) 344-348
11. Kim H.L., Lee D.S., Yang S.H., Lim C.S., Chung J.H., Kim S., et al. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am. J. Kidney Dis. 40 (2002) 1146-1152
12. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
13. McDermott D.H., Yang Q., Kathiresan S., Cupples L.A., Massaro J.M., Keaney Jr. J.F., et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation 112 (2005) 1113-1120
14. Tabara Y., Kohara K., Yamamoto Y., Igase M., Nakura J., Kondo I., et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens. Res. 26 (2003) 677-683
15. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., and Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N. Engl. J. Med. 340 (1999) 14-22
16. Blin N., and Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3 (1976) 2303-2308
17. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88 (1991) 1121-1127
18. Martinovic I., Abegunewardene N., Seul M., Vosseler M., Horstick G., Buerke M., et al. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ. J. 69 (2005) 1484-1489
19. Chiarelli F., Cipollone F., Mohn A., Marini M., Iezzi A., Fazia M., et al. Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 25 (2002) 1829-1834
20. Banba N., Nakamura T., Matsumura M., Kuroda H., Hattori Y., and Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 58 (2000) 684-690
21. Morii T., Fujita H., Narita T., Shimotomai T., Fujishima H., Yoshioka N., et al. Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. J. Diabetes Complications 17 (2003) 11-15
22. Tashiro K., Koyanagi I., Saitoh A., Shimizu A., Shike T., Ishiguro C., et al. Urinary levels of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8), and renal injuries in patients with type 2 diabetic nephropathy. J. Clin. Lab. Anal. 16 (2002) 1-4
23. Gonzalez E., Rovin B.H., Sen L., Cooke G., Dhanda R., Mummidi S., et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13795-13800
24. Cho M.L., Kim J.Y., Ko H.J., Kim Y.H., Kim W.U., Cho C.S., et al. The MCP-1 promoter -2518 polymorphism in Behcet's disease: correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 37 (2004) 77-80
25. Simeoni E., Hoffmann M.M., Winkelmann B.R., Ruiz J., Fleury S., Boehm B.O., et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia 47 (2004) 1574-1580
26. Zietz B., Buchler C., Herfarth H., Muller-Ladner U., Spiegel D., Scholmerich J., et al. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A → G promoter polymorphism. Diabetes Obes. Metab. 7 (2005) 570-578
27. Inadera H., Egashira K., Takemoto M., Ouchi Y., and Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J. Interferon Cytokine Res. 19 (1999) 1179-1182
28. Frazier-Jessen M.R., and Kovacs E.J. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154 (1995) 1838-1845
29. Pervin S., Singh R., Rosenfeld M.E., Navab M., Chaudhuri G., and Nathan L. Estradiol suppresses MCP-1 expression in vivo: implications for atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1575-1582